Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-20-000047
Filing Date
2020-02-07
Accepted
2020-02-07 10:38:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G FINAL ANNUAL FILING (MRNS) MRNS1219.txt SC 13G/A 7118
  Complete submission text file 0000053417-20-000047.txt   8741
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Subject) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88269 | Film No.: 20585234
SIC: 2834 Pharmaceutical Preparations